New hope for inoperable liver cancer? early trial tests drug combo
NCT ID NCT05546879
Summary
This early-stage study is testing the safety of adding a new drug called NP137 to the standard two-drug treatment for advanced liver cancer that cannot be removed by surgery. The goal is to see if this three-drug combination is safe and might help patients live longer or shrink their tumors better than the standard treatment alone. The study is currently suspended and will involve about 43 patients who have not had prior drug treatment for their advanced cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de GRENOBLE ALPES
Grenoble, Alpes, 38043, France
Conditions
Explore the condition pages connected to this study.